Argos Wealth Advisors LLC Buys Shares of 9,575 Cognex Corporation $CGNX

Argos Wealth Advisors LLC bought a new stake in Cognex Corporation (NASDAQ:CGNX) in the 4th quarter, according to its most recent disclosure with the SEC. The fund bought 9,575 shares of the scientific and technical instruments company’s stock, valued at approximately $345,000.

Other institutional investors also recently bought and sold shares of the company. Vanguard Group Inc. grew its position in shares of Cognex by 2.1% during the third quarter. Vanguard Group Inc. now owns 18,598,728 shares of the scientific and technical instruments company’s stock worth $842,522,000 after buying an additional 374,999 shares in the last quarter. Nordea Investment Management AB grew its position in shares of Cognex by 0.9% during the fourth quarter. Nordea Investment Management AB now owns 8,101,583 shares of the scientific and technical instruments company’s stock worth $292,224,000 after buying an additional 76,212 shares in the last quarter. Pictet Asset Management Holding SA grew its position in shares of Cognex by 27.9% during the fourth quarter. Pictet Asset Management Holding SA now owns 7,013,184 shares of the scientific and technical instruments company’s stock worth $252,360,000 after buying an additional 1,529,010 shares in the last quarter. Disciplined Growth Investors Inc. MN grew its position in shares of Cognex by 0.9% during the second quarter. Disciplined Growth Investors Inc. MN now owns 4,768,716 shares of the scientific and technical instruments company’s stock worth $151,264,000 after buying an additional 40,927 shares in the last quarter. Finally, Bank of New York Mellon Corp grew its position in shares of Cognex by 43.9% during the third quarter. Bank of New York Mellon Corp now owns 3,024,355 shares of the scientific and technical instruments company’s stock worth $137,003,000 after buying an additional 922,149 shares in the last quarter. 88.12% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling

In related news, insider Mark Fennell sold 64,873 shares of the stock in a transaction on Monday, May 11th. The stock was sold at an average price of $67.05, for a total transaction of $4,349,734.65. Following the completion of the sale, the insider directly owned 11,263 shares of the company’s stock, valued at $755,184.15. This trade represents a 85.21% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Angelos Papadimitriou sold 4,150 shares of the stock in a transaction on Monday, February 23rd. The stock was sold at an average price of $55.58, for a total value of $230,657.00. Following the sale, the director directly owned 16,222 shares of the company’s stock, valued at approximately $901,618.76. This represents a 20.37% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 208,745 shares of company stock valued at $13,862,237 over the last three months. 1.70% of the stock is currently owned by company insiders.

Cognex Trading Down 3.1%

CGNX stock opened at $63.65 on Thursday. The company has a market capitalization of $10.59 billion, a P/E ratio of 75.77 and a beta of 1.48. Cognex Corporation has a twelve month low of $29.00 and a twelve month high of $71.90. The business has a 50 day simple moving average of $53.50 and a 200-day simple moving average of $45.71.

Cognex (NASDAQ:CGNX) last posted its quarterly earnings data on Wednesday, May 6th. The scientific and technical instruments company reported $0.34 earnings per share for the quarter, beating the consensus estimate of $0.25 by $0.09. The business had revenue of $268.44 million during the quarter, compared to the consensus estimate of $245.98 million. Cognex had a return on equity of 10.89% and a net margin of 13.62%.The company’s revenue was up 24.3% compared to the same quarter last year. During the same period in the prior year, the company earned $0.14 earnings per share. Cognex has set its Q2 2026 guidance at 0.400-0.440 EPS. Research analysts predict that Cognex Corporation will post 1.05 EPS for the current fiscal year.

Cognex Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, June 4th. Investors of record on Thursday, May 21st will be issued a dividend of $0.085 per share. The ex-dividend date of this dividend is Thursday, May 21st. This represents a $0.34 annualized dividend and a dividend yield of 0.5%. Cognex’s dividend payout ratio (DPR) is currently 40.48%.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently commented on the company. Stephens boosted their price objective on Cognex from $65.00 to $75.00 and gave the stock an “overweight” rating in a research report on Thursday, May 7th. Truist Financial set a $61.00 price target on Cognex and gave the company a “hold” rating in a report on Friday, May 8th. Needham & Company LLC upped their price target on Cognex from $67.00 to $75.00 and gave the company a “buy” rating in a report on Friday, May 8th. Robert W. Baird set a $72.00 price target on Cognex in a report on Friday, May 8th. Finally, Zacks Research downgraded Cognex from a “strong-buy” rating to a “hold” rating in a report on Tuesday, April 14th. One investment analyst has rated the stock with a Strong Buy rating, ten have given a Buy rating and seven have issued a Hold rating to the stock. According to data from MarketBeat.com, Cognex has a consensus rating of “Moderate Buy” and an average target price of $68.86.

Cognex Company Profile

Cognex Corporation is a leading provider of machine vision systems, software, sensors and industrial barcode readers used to automate manufacturing, logistics and distribution processes. The company designs and develops vision-based products that help manufacturers and logistics operators inspect, identify and guide parts, assemblies and packaged goods in real time. Its solutions are applied in a broad range of industries, including automotive, electronics, semiconductor, pharmaceutical, food and beverage, and general manufacturing.

The company’s product portfolio includes stand-alone vision systems, vision sensors and deep learning-based software platforms that enable automated inspection, quality control and traceability.